Exercise Training and Plasma Lipoproteins in Man

This study has been completed.
Sponsor:
Collaborator:
Information provided by (Responsible Party):
Stanford University
ClinicalTrials.gov Identifier:
NCT00000519
First received: October 27, 1999
Last updated: June 25, 2013
Last verified: June 2013

October 27, 1999
June 25, 2013
July 1982
Not Provided
Not Provided
Not Provided
Complete list of historical versions of study NCT00000519 on ClinicalTrials.gov Archive Site
Not Provided
Not Provided
Not Provided
Not Provided
 
Exercise Training and Plasma Lipoproteins in Man
Not Provided

To determine the effects in moderately obese subjects of weight loss by combined dieting and exercise training on risk factors for coronary artery disease including lipoprotein lipids, apoproteins and blood pressure.

BACKGROUND:

Evidence appears to be fairly conclusive that obesity has adverse effects on health and longevity when the relative body weight is 40 percent above desirable weight based on insurance industry tables of weights. The close association between obesity, hypertension, hypercholesterolemia, non-insulin dependent diabetes mellitus, an excess of certain cancers and other medical problems makes it imperative that interventions be directed to change the lifestyles and behaviors of individuals who are overweight. The Stanford Weight Control Project (SWCP) trial examined the effects of weight loss on cardiovascular disease risk factors.

The Stanford Weight Control Project (SWCP) randomized 155 overweight, sedentary, non-smoking men, aged 30-59 years, to one of three groups. Fifty-one were assigned to weight loss through dieting, 52 to weight loss through exercise, and 52 to a control, non-intervention group. Follow-up continued through July 1989.

DESIGN NARRATIVE:

Subjects were randomized to a control group, a hypocaloric National Cholesterol Education Program (NCEP) diet, or to a hypocaloric NCEP diet with exercise. One hundred nineteen of the men and 112 of the women returned for testing after one year.

Interventional
Phase 3
Allocation: Randomized
Primary Purpose: Prevention
  • Cardiovascular Diseases
  • Coronary Disease
  • Heart Diseases
  • Hypertension
  • Myocardial Ischemia
  • Obesity
  • Behavioral: diet, reducing
  • Behavioral: exercise
  • Behavioral: diet, fat-restricted
Not Provided

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Completed
Not Provided
Not Provided
Not Provided

Men and women, ages 25-49. Subjects were overweight with blood pressure less than 160/95 mm Hg and total cholesterol less than 260 mm/dl.

Both
25 Years to 49 Years
No
Contact information is only displayed when the study is recruiting subjects
Not Provided
 
NCT00000519
38, R01HL024462
Not Provided
Stanford University
Stanford University
National Heart, Lung, and Blood Institute (NHLBI)
Not Provided
Stanford University
June 2013

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP